메뉴 건너뛰기
Interactive Cardiovascular and Thoracic Surgery
Volumn 6, Issue 4, 2007, Pages 519-522
Does enteric-coated aspirin result in a lower incidence of gastrointestinal complications compared to normal aspirin?
Author keywords

Aspirin; Coronary artery bypass grafts; Enteric coated tablets; Gastrointestinal complications
Indexed keywords

ACETYLSALICYLIC ACID;
EID: 34548435180     PISSN: 15699293     EISSN: None     Source Type: Journal    
DOI: 10.1510/icvts.2007.155788     Document Type: Article
Times cited : (38)
References (10)
  • 1
    • 1642498167 scopus 로고    scopus 로고
    • Towards evidence-based medicine in cardiothoracic surgery: Best BETS. Interactive CardioVasc
    • Dunning J, Prendergast B, Mackway-Jones K. Towards evidence-based medicine in cardiothoracic surgery: best BETS. Interactive CardioVasc Thorac Surg 2003;2:405-409.
    • (2003) Thorac Surg , vol.2 , pp. 405-409
    • Dunning, J.1    Prendergast, B.2    Mackway-Jones, K.3
  • 3
    • 0032816044 scopus 로고    scopus 로고
    • Enteric coating of aspirin significantly decreases gastroduodenal mucosal lesions
    • Dammann HG, Burkhardt F, Wolf N. Enteric coating of aspirin significantly decreases gastroduodenal mucosal lesions. Aliment Pharm Therap 1999;13:1109-1114.
    • (1999) Aliment Pharm Therap , vol.13 , pp. 1109-1114
    • Dammann, H.G.1    Burkhardt, F.2    Wolf, N.3
  • 4
    • 0034128496 scopus 로고    scopus 로고
    • Gastroduodenal tolerability of medium dose enteric-coated aspirin: A placebo controlled endoscopic study of a new enteric-coated formulation vs. regular formulation in healthy volunteers
    • Apr;
    • Blondon H, Barbier JP, Mahe I, Deverly A, Kolsky H, Bergmann JF. Gastroduodenal tolerability of medium dose enteric-coated aspirin: a placebo controlled endoscopic study of a new enteric-coated formulation vs. regular formulation in healthy volunteers. Fund Clin Pharmacol 2000 Apr;14:155-157.
    • (2000) Fund Clin Pharmacol , vol.14 , pp. 155-157
    • Blondon, H.1    Barbier, J.P.2    Mahe, I.3    Deverly, A.4    Kolsky, H.5    Bergmann, J.F.6
  • 5
    • 0025894896 scopus 로고
    • Aspirin-induced gastric mucosal damage: Prevention by enteric-coating and relation to prostaglandin synthesis
    • Hawthorne AB, Mahida YR, Cole AT, Hawkey CJ. Aspirin-induced gastric mucosal damage: prevention by enteric-coating and relation to prostaglandin synthesis. Br J Clin Pharmacol 1991;32:77-83.
    • (1991) Br J Clin Pharmacol , vol.32 , pp. 77-83
    • Hawthorne, A.B.1    Mahida, Y.R.2    Cole, A.T.3    Hawkey, C.J.4
  • 6
    • 0027245798 scopus 로고
    • Endoscopic comparison of three aspirin preparations and placebo
    • Apr;
    • Petroski D. Endoscopic comparison of three aspirin preparations and placebo. Clin Ther 1993 Apr;15:314-320.
    • (1993) Clin Ther , vol.15 , pp. 314-320
    • Petroski, D.1
  • 7
    • 0030599533 scopus 로고    scopus 로고
    • Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product. wsee commentx
    • Kelly JP, Kaufman DW, Jurgelon JM, Sheehan J, Koff RS, Shapiro S. Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product. wsee commentx. Lancet 1996;348:1413-1416.
    • (1996) Lancet , vol.348 , pp. 1413-1416
    • Kelly, J.P.1    Kaufman, D.W.2    Jurgelon, J.M.3    Sheehan, J.4    Koff, R.S.5    Shapiro, S.6
  • 8
    • 0001834897 scopus 로고    scopus 로고
    • Risk of upper gastrointestinal bleeding and perforation associated with low-dose aspirin as plain and enteric-coated formulations
    • de Abajo FJ, Garcia Rodriguez LA. Risk of upper gastrointestinal bleeding and perforation associated with low-dose aspirin as plain and enteric-coated formulations. BMC Clinical Pharmacology 2001;1:1.
    • (2001) BMC Clinical Pharmacology , vol.1 , pp. 1
    • de Abajo, F.J.1    Garcia Rodriguez, L.A.2
  • 9
    • 1842734425 scopus 로고    scopus 로고
    • Concomitant use of buffered and enteric-coated low-dose aspirin products and antisecretory drugs
    • Takada M, Fukumoto K, Shibakawa M. Concomitant use of buffered and enteric-coated low-dose aspirin products and antisecretory drugs. J Clin Pharm Ther 2004;29:183-187.
    • (2004) J Clin Pharm Ther , vol.29 , pp. 183-187
    • Takada, M.1    Fukumoto, K.2    Shibakawa, M.3
  • 10
    • 0036140573 scopus 로고    scopus 로고
    • Risk of gastric injury with enteric- vs. nonenteric-coated aspirin
    • Banoob DW, McCloskey WW, Webster W. Risk of gastric injury with enteric- vs. nonenteric-coated aspirin. Ann Pharmacother 2002;36:163-166.
    • (2002) Ann Pharmacother , vol.36 , pp. 163-166
    • Banoob, D.W.1    McCloskey, W.W.2    Webster, W.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.